171 related articles for article (PubMed ID: 15529177)
21. PML induces a novel caspase-independent death process.
Quignon F; De Bels F; Koken M; Feunteun J; Ameisen JC; de Thé H
Nat Genet; 1998 Nov; 20(3):259-65. PubMed ID: 9806544
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
23. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
25. Effects of red orpiment on cell morphology and expression of PML mRNA and protein in NB4 and HL-60 cells.
Zhong L; Chen F; Han J; Shao N; Ouyang R
Chin Med J (Engl); 2003 Jan; 116(1):148-50. PubMed ID: 12667410
[TBL] [Abstract][Full Text] [Related]
26. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
28. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
Day PM; Baker CC; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
[TBL] [Abstract][Full Text] [Related]
29. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
30. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.
Yu JH; Nakajima A; Nakajima H; Diller LR; Bloch KD; Bloch DB
Cancer Res; 2004 Feb; 64(3):928-33. PubMed ID: 14871822
[TBL] [Abstract][Full Text] [Related]
31. The function of PML in p53-dependent apoptosis.
Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
[TBL] [Abstract][Full Text] [Related]
32. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
[TBL] [Abstract][Full Text] [Related]
33. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
[TBL] [Abstract][Full Text] [Related]
35. Role of promyelocytic leukemia (PML) protein in tumor suppression.
Rego EM; Wang ZG; Peruzzi D; He LZ; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2001 Feb; 193(4):521-29. PubMed ID: 11181703
[TBL] [Abstract][Full Text] [Related]
36. Promyelocytic leukemia protein is required for gain of function by mutant p53.
Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
[TBL] [Abstract][Full Text] [Related]
37. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
38. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
40. [Study of the effects of quercetin on PML gene and protein expression and localization in leukemia cells].
Zhong L; Chen F; Han J; Shao N; Ouyang R
Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):87-90. PubMed ID: 12015078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]